Eli Lilly's (LLY) CEO says that the number of people engaging with the Lilly direct has increased to over 1mln patients in 2025
Importance
Level 1
- Eli Lilly (LLY) exec says that price is expected to drag on growth in the low to mid teens range in 2026.
- Company also plans to launch its obesity pill outside the US in 2027.
#ELI LILLY & CO#LLY.US#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ELI LILLY AND CO#LLY#US EQUITIES